|
US3378587A
(en)
|
1963-03-14 |
1968-04-16 |
Du Pont |
3, 3'-diaminomethyl-1, 1'-biadamantane
|
|
NL127995C
(fr)
|
1963-12-20 |
|
Geigy Ag J R |
|
|
US3341538A
(en)
|
1965-06-18 |
1967-09-12 |
Geigy Chem Corp |
Certain 2, 6-methano-3-benzazocines
|
|
DE2108954A1
(en)
|
1971-02-25 |
1972-09-07 |
Boehringer Sohn Ingelheim |
2-(furylmethyl)-6,7-benzomorphans - useful as cns active agents
|
|
DE1801556A1
(de)
|
1968-10-05 |
1970-05-21 |
Huels Chemische Werke Ag |
Verfahren zur Herstellung von substituierten Hexahydropyrimidinonen-(2)
|
|
GB1304175A
(fr)
|
1969-03-31 |
1973-01-24 |
|
|
|
DE2105743C3
(de)
|
1971-02-08 |
1979-11-29 |
Boehringer Sohn Ingelheim |
2-(Furylmethyl)- a -5,9-dialkyl -6,7benzomorphane, Verfahren zu ihrer Herstellung und deren Verwendung
|
|
US3681349A
(en)
|
1970-03-05 |
1972-08-01 |
Morton Norwich Products Inc |
1-(substituted benzyl) tetrahydro-2-(1h) pyrimidones
|
|
US4043927A
(en)
|
1972-03-07 |
1977-08-23 |
Sun Ventures, Inc. |
Friction or tractive drive containing ethers of adamantanes
|
|
DE2229695A1
(de)
|
1972-06-19 |
1974-01-31 |
Boehringer Sohn Ingelheim |
2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
|
|
DE2338369A1
(de)
|
1973-07-26 |
1975-02-13 |
Schering Ag |
Mikrobiologische hydroxylierung von 2,6-methano-3-benzazocinen
|
|
SU510999A3
(ru)
|
1973-10-27 |
1976-04-15 |
К.Х.Берингер Зон, (Фирма) |
Способ получени (метоксиметил-фурилметил)6,7-бензоморфанов илиморфинанов
|
|
US4009171A
(en)
|
1974-02-21 |
1977-02-22 |
Sterling Drug Inc. |
N-acylated-11-oxygenated-2,6-methano-3-benzazocine intermediates
|
|
DE2411382C3
(de)
|
1974-03-09 |
1979-09-06 |
C.H. Boehringer Sohn, 6507 Ingelheim |
2-Tetrahydrofurfuryl-6,7-benzomorphane, Verfahren zur Herstellung und deren Verwendung
|
|
US4136145A
(en)
|
1974-07-05 |
1979-01-23 |
Schering Aktiengesellschaft |
Medicament carriers in the form of film having active substance incorporated therein
|
|
US4136162A
(en)
|
1974-07-05 |
1979-01-23 |
Schering Aktiengesellschaft |
Medicament carriers in the form of film having active substance incorporated therein
|
|
DE2437610A1
(de)
|
1974-08-05 |
1976-02-26 |
Boehringer Sohn Ingelheim |
Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung
|
|
GB1513961A
(en)
|
1975-02-25 |
1978-06-14 |
Acf Chemiefarma Nv |
6,7-benzomorphans method for their preparation and intermediates
|
|
US4108857A
(en)
|
1975-08-18 |
1978-08-22 |
Sterling Drug Inc. |
Imidazolylmethyl methanobenzazocines
|
|
DE2828039A1
(de)
|
1978-06-26 |
1980-01-10 |
Boehringer Sohn Ingelheim |
2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
|
|
CA2023492A1
(fr)
|
1989-08-31 |
1991-03-01 |
Barry Clifford Lange |
Glutarimides synthetiques
|
|
US5393735A
(en)
|
1990-08-09 |
1995-02-28 |
Rohm And Haas Company |
Herbicidal glutarimides
|
|
US5098916A
(en)
|
1990-03-29 |
1992-03-24 |
G. D. Searle & Co. |
Propanobicyclic amine derivatives for cns disorders
|
|
EP0454444A1
(fr)
|
1990-04-24 |
1991-10-30 |
Nissan Chemical Industries Ltd. |
Dérivés du glutarimide et herbicides
|
|
US5215992A
(en)
|
1990-04-30 |
1993-06-01 |
G. D. Searle & Co. |
Ethanobicyclic amine derivatives for CNS disorders
|
|
US5089506A
(en)
|
1990-04-30 |
1992-02-18 |
G. D. Searle & Co. |
Ethanobicyclic amine derivatives for cns disorders
|
|
DK204291D0
(da)
|
1991-12-20 |
1991-12-20 |
Novo Nordisk As |
Heterocykliske forbindelser deres fremstilling og anvendelse
|
|
CA2049244A1
(fr)
|
1990-08-16 |
1992-02-17 |
Steven H. Christiansen |
Methode d'absorption de composes sulfures a partir de fluides grace a des composes heterocycliques renfermant au moins un atome d'azote cyclique
|
|
MY108616A
(en)
|
1990-10-10 |
1996-10-31 |
Schering Corp |
Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines of piperazines, and compositions and methods of use thereof
|
|
GB9023583D0
(en)
|
1990-10-30 |
1990-12-12 |
Beecham Group Plc |
Novel compounds
|
|
SK280882B6
(sk)
|
1991-10-11 |
2000-08-14 |
The Du Pont Merck Pharmaceutical Company |
Cyklické močoviny, ich analógy a farmaceutické prípravky na ich báze
|
|
US5610294A
(en)
|
1991-10-11 |
1997-03-11 |
The Du Pont Merck Pharmaceutical Company |
Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
|
|
ATE194981T1
(de)
|
1992-04-30 |
2000-08-15 |
Taiho Pharmaceutical Co Ltd |
Oxazolidinderivat und sein pharmazeutisch verträgliches salz
|
|
GB9225377D0
(en)
|
1992-12-04 |
1993-01-27 |
Ici Plc |
Herbicides
|
|
KR0173145B1
(ko)
|
1993-04-07 |
1999-02-01 |
고바야시 유키오 |
티아졸리딘 유도체 및 이를 함유하는 약학적 조성물
|
|
TW280812B
(fr)
|
1993-07-02 |
1996-07-11 |
Bayer Ag |
|
|
EP0640594A1
(fr)
|
1993-08-23 |
1995-03-01 |
Fujirebio Inc. |
Dérivé de hydantoine comme inhibiteur de métalloprotease
|
|
DE19500118A1
(de)
|
1994-05-18 |
1995-11-23 |
Bayer Ag |
Substituierte Diazacyclohexandi(thi)one
|
|
WO1996014297A1
(fr)
|
1994-11-04 |
1996-05-17 |
Sumitomo Pharmaceuticals Company, Limited |
Nouveaux derives de lactame
|
|
FR2729954B1
(fr)
|
1995-01-30 |
1997-08-01 |
Sanofi Sa |
Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
|
|
US5780466A
(en)
|
1995-01-30 |
1998-07-14 |
Sanofi |
Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present
|
|
GB9510459D0
(en)
|
1995-05-24 |
1995-07-19 |
Zeneca Ltd |
Bicyclic amines
|
|
US5776959A
(en)
|
1995-06-05 |
1998-07-07 |
Washington University |
Anticonvulsant and anxiolytic lactam and thiolactam derivatives
|
|
GB9517622D0
(en)
|
1995-08-29 |
1995-11-01 |
Univ Edinburgh |
Regulation of intracellular glucocorticoid concentrations
|
|
WO1997036605A1
(fr)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibiteurs de farnesyl-proteine transferase
|
|
WO1998004534A1
(fr)
|
1996-07-31 |
1998-02-05 |
Nikken Chemicals Co., Ltd. |
Derives de 6-phenyltetrahydro-1,3-oxazine-2-one et compositions medicinales a base de ces composes
|
|
US6794390B2
(en)
|
1996-08-02 |
2004-09-21 |
Cv Therapeutics, Inc. |
Purine inhibitors of cyclin dependent kinase 2 & ikappabalpha
|
|
US5866702A
(en)
|
1996-08-02 |
1999-02-02 |
Cv Therapeutics, Incorporation |
Purine inhibitors of cyclin dependent kinase 2
|
|
GB9623944D0
(en)
|
1996-11-15 |
1997-01-08 |
Zeneca Ltd |
Bicyclic amine derivatives
|
|
US6159990A
(en)
|
1997-06-18 |
2000-12-12 |
Synaptic Pharmaceutical Corporation |
Oxazolidinones as α1A receptor antagonists
|
|
AU740064B2
(en)
|
1997-06-18 |
2001-10-25 |
H. Lundbeck A/S |
Heterocyclic substituted piperidines and uses thereof
|
|
DE19731784A1
(de)
|
1997-07-24 |
1999-02-04 |
Bayer Ag |
Substituierte N-Aryl-N-thioxocarbonyl-sulfonamide
|
|
GB9715892D0
(en)
|
1997-07-29 |
1997-10-01 |
Zeneca Ltd |
Heterocyclic compounds
|
|
US5936124A
(en)
|
1998-06-22 |
1999-08-10 |
Sepacor Inc. |
Fluoxetine process from benzoylpropionic acid
|
|
US7410995B1
(en)
|
1998-08-14 |
2008-08-12 |
Gpi Nil Holdings Inc. |
N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders
|
|
DE19918725A1
(de)
|
1999-04-24 |
2000-10-26 |
Bayer Ag |
Substituierte N-Cyano-sulfonsäureanilide
|
|
DE19929348A1
(de)
|
1999-06-26 |
2000-12-28 |
Bayer Ag |
Verfahren zur Herstellung von 2-Heterocyclylmethyl-benzoesäurederivaten
|
|
US7256005B2
(en)
|
1999-08-10 |
2007-08-14 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
|
|
EP1206262A4
(fr)
|
1999-08-26 |
2003-01-02 |
Bristol Myers Squibb Co |
Antagonistes des neuropeptides y: derives de spiroisoquinolinone
|
|
ES2258485T3
(es)
|
1999-12-17 |
2006-09-01 |
Schering Corporation |
Antagonistas selectivos de neuroquinina.
|
|
US6436928B1
(en)
|
1999-12-17 |
2002-08-20 |
Schering Corporation |
Selective neurokinin antagonists
|
|
WO2001055063A1
(fr)
|
2000-01-25 |
2001-08-02 |
Idemitsu Petrochemical Co., Ltd. |
Nouveaux composes a base de bisadamantane, procedes de production et nouveaux derives de bisadamantane
|
|
GB0003397D0
(en)
|
2000-02-14 |
2000-04-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
DE10034623A1
(de)
|
2000-07-17 |
2002-01-31 |
Bayer Ag |
Heterocyclisch substituierte Pyridine als Cytokin-Inhibitoren
|
|
DE10034800A1
(de)
|
2000-07-18 |
2002-01-31 |
Bayer Ag |
Substituierte Benzostickstoffheterocyclen
|
|
DE10034803A1
(de)
|
2000-07-18 |
2002-01-31 |
Bayer Ag |
Substituierte Sulfonsäureanilide
|
|
DE10035928A1
(de)
|
2000-07-21 |
2002-03-07 |
Asta Medica Ag |
Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
|
|
DE10035908A1
(de)
|
2000-07-21 |
2002-03-07 |
Asta Medica Ag |
Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
|
|
DE10035927A1
(de)
|
2000-07-21 |
2002-03-07 |
Asta Medica Ag |
Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
|
|
DE60114227T2
(de)
|
2000-08-16 |
2006-04-20 |
Neurogen Corp., Branford |
2,4-substituierte pyridinderivate
|
|
US7294637B2
(en)
|
2000-09-11 |
2007-11-13 |
Sepracor, Inc. |
Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
|
|
JP2004509103A
(ja)
|
2000-09-11 |
2004-03-25 |
セプレイコー インコーポレイテッド |
モノアミン受容体及び輸送体のリガンドならびにその使用方法
|
|
JP2002179572A
(ja)
|
2000-10-06 |
2002-06-26 |
Nikken Chem Co Ltd |
アレルギー性眼疾患治療剤
|
|
US6841671B2
(en)
|
2000-10-26 |
2005-01-11 |
Pfizer Inc. |
Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
|
|
US20030143668A1
(en)
|
2001-06-18 |
2003-07-31 |
National Institute Of Advanced Industrial |
Guanosine triphosphate-binding protein coupled receptors
|
|
JP3873115B2
(ja)
|
2001-09-25 |
2007-01-24 |
独立行政法人産業技術総合研究所 |
環状ウレタン製造方法
|
|
JP4545437B2
(ja)
|
2001-10-15 |
2010-09-15 |
シェーリング コーポレイション |
アデノシンａ２ａ受容体アンタゴニストとしてのイミダゾ（４，３−ｅ）−１，２，４−トリアゾロ（１，５−ｃ）ピリミジン
|
|
CN1578767A
(zh)
|
2001-11-22 |
2005-02-09 |
小野药品工业株式会社 |
哌啶－2－酮衍生化合物及包含其作为活性成分的药学组合物
|
|
WO2003057673A1
(fr)
|
2001-12-28 |
2003-07-17 |
Bayer Pharmaceuticals Corporation |
Composes derives de 1h-pyrozolyle, pouvant etre utilises dans les maladies associees au recepteur 5-ht2c
|
|
JP2003300884A
(ja)
|
2002-04-08 |
2003-10-21 |
Nikken Chem Co Ltd |
ＴＮＦ−α産生阻害剤
|
|
WO2003091258A1
(fr)
|
2002-04-26 |
2003-11-06 |
Pfizer Products Inc. |
Inhibiteurs de la metalloproteinase n-substitues-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione
|
|
ATE304015T1
(de)
|
2002-04-26 |
2005-09-15 |
Pfizer Prod Inc |
Triaryl-oxy-aryl-spiro-pyrimidin-2, 4, 6-trion metalloproteinase inhibitoren
|
|
JP4500161B2
(ja)
|
2002-04-30 |
2010-07-14 |
クドス ファーマシューティカルズ リミテッド |
フタラジノン誘導体
|
|
EP1506174B1
(fr)
|
2002-05-17 |
2015-09-30 |
Taiwanj Pharmaceuticals Co., Ltd. |
Utilisation de la naltrexone pour le traitement de lésions hépatiques et rénales
|
|
MXPA05000196A
(es)
|
2002-07-03 |
2005-06-06 |
Schering Corp |
Derivados de 1-amido-4-fenil-4-benciloximetil-piperidina y compuestos relacionados como antagonistas de neurocinina-1(nk-1)para el tratamiento de vomito, depresion, ansiedad y tos.
|
|
AU2003249812A1
(en)
|
2002-07-18 |
2004-02-09 |
Queen's University At Kingston |
Dihydrouracil compounds as anti-ictogenic or anti-epileptogenic agents
|
|
GB0218630D0
(en)
|
2002-08-10 |
2002-09-18 |
Tanabe Seiyaku Co |
Novel compounds
|
|
AR041198A1
(es)
|
2002-10-11 |
2005-05-04 |
Otsuka Pharma Co Ltd |
Compuesto 2,3-dihidro-6-nitroimidazo[2,1-b] oxaxol, y composiciones farmaceuticas que lo contienen
|
|
WO2004046137A1
(fr)
|
2002-11-21 |
2004-06-03 |
Vicore Pharma Ab |
Nouveaux agonistes tricycliques de l'angiotensine ii
|
|
GB0228410D0
(en)
|
2002-12-05 |
2003-01-08 |
Glaxo Group Ltd |
Novel Compounds
|
|
WO2004055008A1
(fr)
|
2002-12-13 |
2004-07-01 |
Smithkline Beecham Corporation |
Composes, compositions et methodes
|
|
WO2004056744A1
(fr)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides utilises comme inhibiteurs de la hydroxysteroide deshydrogenase
|
|
CA2519939A1
(fr)
|
2003-03-26 |
2004-10-14 |
Merck & Co., Inc. |
Derives de piperidine bicycliques utilises comme agonistes du recepteur 4 de la melanocortine
|
|
US7700583B2
(en)
|
2003-04-11 |
2010-04-20 |
High Point Pharmaceuticals, Llc |
11β-hydroxysteroid dehydrogenase type 1 active compounds
|
|
ATE482747T1
(de)
|
2003-04-11 |
2010-10-15 |
High Point Pharmaceuticals Llc |
Neue amide derivate und deren pharmazeutische verwendungen
|
|
EP1613590A2
(fr)
|
2003-04-16 |
2006-01-11 |
Memory Pharmaceutical Corporation |
Composés dérivés de 4-(phényl, 3-4-disubstitué)-pyrrolidin-2-one comme inhibiteurs de la phosphodiesterase 4
|
|
ITMI20031292A1
(it)
|
2003-06-25 |
2004-12-26 |
Nikem Research Srl |
Derivati biciclici nk-2 antagonisti selettivi.
|
|
DE10358004A1
(de)
|
2003-12-11 |
2005-07-14 |
Abbott Gmbh & Co. Kg |
Ketolactam-Verbindungen und ihre Verwendung
|
|
US7186844B2
(en)
|
2004-01-13 |
2007-03-06 |
Mitsubishi Gas Chemical Co., Inc. |
Method for producing cyclic carbamate ester
|
|
JP4324669B2
(ja)
|
2004-01-21 |
2009-09-02 |
独立行政法人産業技術総合研究所 |
環状ウレタンの製造方法
|
|
JP2005239670A
(ja)
|
2004-02-27 |
2005-09-08 |
Ono Pharmaceut Co Ltd |
含窒素複素環化合物およびその医薬用途
|
|
US7619086B2
(en)
|
2004-03-09 |
2009-11-17 |
Merck & Co., Inc. |
HIV integrase inhibitors
|
|
US8519158B2
(en)
|
2004-03-12 |
2013-08-27 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
|
JP2005272321A
(ja)
|
2004-03-23 |
2005-10-06 |
Ono Pharmaceut Co Ltd |
含窒素複素環化合物およびその医薬用途
|
|
ES2525319T3
(es)
|
2004-05-07 |
2014-12-22 |
Janssen Pharmaceutica Nv |
Derivados de pirrolidin-2-ona y piperidin-2-ona como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa
|
|
PL1747198T3
(pl)
|
2004-05-07 |
2008-11-28 |
Janssen Pharmaceutica Nv |
Pochodne adamantylopirolidyn-2-onu jako inhibitory 11ß-dehydrogenazy hydroksysteroidowej
|
|
GB0411404D0
(en)
|
2004-05-21 |
2004-06-23 |
Glaxo Group Ltd |
Novel compounds
|
|
US7253196B2
(en)
|
2004-05-24 |
2007-08-07 |
Amgen, Inc. |
Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
|
|
AU2005258248A1
(en)
|
2004-06-24 |
2006-01-05 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
|
GB0414438D0
(en)
|
2004-06-28 |
2004-07-28 |
Syngenta Participations Ag |
Chemical compounds
|
|
DOP2005000123A
(es)
|
2004-07-02 |
2011-07-15 |
Merck Sharp & Dohme |
Inhibidores de cetp
|
|
EP1621539A1
(fr)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Dérivées d'urée cyclique substitués par un heterocycle, leur prépration et leur utilisation pharmaceutique comee inhibiteurs de kinases
|
|
EP1621535A1
(fr)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Dérivés substitués d'urée cyclique, leur préparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
|
EP1621536A1
(fr)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Dérivés d'urées cycliques aminés, leur préparation et utilisation pharmaceutique en tant qu'inhibiteurs de Kinase
|
|
EP1797054A2
(fr)
|
2004-08-02 |
2007-06-20 |
OSI Pharmaceuticals, Inc. |
Composes a base de pyrrolopyrimidine a substitution arylamine inhibiteurs de kinases multiples
|
|
CN101217958A
(zh)
|
2004-08-23 |
2008-07-09 |
默克公司 |
Akt活性抑制剂
|
|
EP1786774B1
(fr)
|
2004-08-30 |
2009-10-14 |
Janssen Pharmaceutica N.V. |
Derives de lactame tricyclique utilises en tant qu'inhibiteurs de 11-beta-hydroxysteroide deshydrogenase
|
|
UA87328C2
(en)
|
2004-08-30 |
2009-07-10 |
Янссен Фармацевтика Н.В. |
N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
|
US7531565B2
(en)
|
2004-09-10 |
2009-05-12 |
Janssen Pharmaceutica, N.V. |
Imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS)
|
|
WO2006040329A1
(fr)
|
2004-10-12 |
2006-04-20 |
Novo Nordisk A/S |
Composes spiro actifs du type a- hydroxysteroide deshydrogenase de type 1
|
|
EP1809626A2
(fr)
|
2004-10-13 |
2007-07-25 |
Neurogen Corporation |
Composes de 8-azabicyclo[3.2.1]octane a substitution aryle comme ligands du recepteur de l'hormone de concentration de la melanine
|
|
PT1807072E
(pt)
|
2004-10-29 |
2009-02-16 |
Lilly Co Eli |
Derivados de cicloalquil lactama como inibidores de 11- beta-hidroxi-esteróide desidrogenase 1
|
|
EA019747B1
(ru)
|
2004-11-10 |
2014-06-30 |
Инсайт Корпорейшн |
Лактамные соединения и их применение в качестве фармацевтических препаратов
|
|
US20060167044A1
(en)
|
2004-12-20 |
2006-07-27 |
Arnaiz Damian O |
Piperidine derivatives and their use as anti-inflammatory agents
|
|
CA2591940A1
(fr)
|
2004-12-23 |
2006-06-29 |
Chiesi Farmaceutici S.P.A. |
Derives d'azole a activite antimuscarinique
|
|
WO2006071819A1
(fr)
|
2004-12-28 |
2006-07-06 |
Exelixis, Inc. |
Composes piperazine ou [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine utilises en tant que modulateurs des serine-theoronine kinases (p70s6k, atk1 et atk2) pour le traitement de maladies immunologiques, inflammatoires et proliferantes
|
|
CN101107245A
(zh)
|
2005-01-19 |
2008-01-16 |
神经能质公司 |
经杂芳基取代的哌嗪-吡啶类似物
|
|
JP2008530216A
(ja)
|
2005-02-16 |
2008-08-07 |
シェーリング コーポレイション |
Ｃｘｃｒ３アンタゴニスト活性を有する、複素環で置換された新規のピリジンまたはフェニル化合物
|
|
CA2598489A1
(fr)
|
2005-02-16 |
2006-08-24 |
Schering Corporation |
Piperazine-piperidines a activite antagoniste cxcr3
|
|
JP4688889B2
(ja)
|
2005-02-16 |
2011-05-25 |
シェーリング コーポレイション |
Ｃｘｃｒ３アンタゴニスト活性を有する、アミン結合ピリジルおよびフェニルで置換されたピペラジン−ピペリジン
|
|
RU2007134259A
(ru)
|
2005-02-16 |
2009-03-27 |
Шеринг Корпорейшн (US) |
Гетероциклические замещенные пиперазины, обладающие антагонистическим действием к cxcr3
|
|
US7868005B2
(en)
|
2005-02-16 |
2011-01-11 |
Schering Corporation |
Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity
|
|
CA2598457A1
(fr)
|
2005-02-16 |
2006-08-24 |
Schering Corporation |
Piperazine-piperidines pyridyl et phenyl substituees a activite antagoniste des cxcr3
|
|
US20080274892A1
(en)
|
2005-02-24 |
2008-11-06 |
Tomokazu Hino |
Novel Haloalkylsulfonanilide Derivative, Herbicide, and Method of Use Thereof
|
|
JPWO2006104280A1
(ja)
|
2005-03-31 |
2008-09-11 |
武田薬品工業株式会社 |
糖尿病の予防・治療剤
|
|
CN101193887A
(zh)
|
2005-04-12 |
2008-06-04 |
维科尔药物公司 |
新颖的三环血管紧张素ⅱ激动剂
|
|
WO2007008529A2
(fr)
|
2005-07-08 |
2007-01-18 |
Kalypsys, Inc |
Agents modificateurs de l'absorption du cholesterol cellulaire
|
|
EP1924265A4
(fr)
|
2005-08-16 |
2010-06-02 |
Genzyme Corp |
Composes se liant aux recepteurs de chimiokine
|
|
CN101341147A
(zh)
|
2005-10-11 |
2009-01-07 |
先灵公司 |
具有cxcr3拮抗剂活性的取代的杂环化合物
|
|
CN101296902A
(zh)
|
2005-10-27 |
2008-10-29 |
Ucb医药有限公司 |
包含内酰胺或内酰胺衍生部分的化合物、制备它们的方法和它们的用途
|
|
EA200801243A1
(ru)
|
2005-11-01 |
2008-10-30 |
Транстек Фарма |
Фармацевтическое применение замещенных амидов
|
|
JP2007140188A
(ja)
|
2005-11-18 |
2007-06-07 |
Fujifilm Corp |
ポジ型感光性組成物及びそれを用いたパターン形成方法
|
|
WO2007061661A2
(fr)
|
2005-11-22 |
2007-05-31 |
Amgen Inc. |
Inhibiteurs de la 11-beta-hydroxy steroide deshydrogenase de type 1
|
|
CA2630492C
(fr)
|
2005-12-05 |
2015-04-14 |
Incyte Corporation |
Composes spiro-lactames
|
|
EP1801098A1
(fr)
|
2005-12-16 |
2007-06-27 |
Merck Sante |
Dérivés de 2-Adamantylurea comme inhibiteurs de 11B-HSD1
|
|
WO2007076055A2
(fr)
|
2005-12-22 |
2007-07-05 |
Entremed, Inc. |
Compositions et methodes comprenant l'utilisation d'antagonistes du recepteur active par des proteases
|
|
DE102005062990A1
(de)
|
2005-12-28 |
2007-07-05 |
Grünenthal GmbH |
Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln
|
|
AU2006332681B2
(en)
|
2005-12-30 |
2011-04-07 |
Merck Sharp & Dohme Corp. |
1, 3-oxazolidin-2-one derivatives useful as CETP inhibitors
|
|
WO2007081569A2
(fr)
|
2005-12-30 |
2007-07-19 |
Merck & Co., Inc. |
Inhibiteurs de cetp
|
|
JP5192392B2
(ja)
|
2005-12-30 |
2013-05-08 |
メルク・シャープ・エンド・ドーム・コーポレイション |
コレステリルエステル転送タンパク質阻害剤
|
|
JP5199121B2
(ja)
|
2005-12-30 |
2013-05-15 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Ｃｅｔｐ阻害剤
|
|
WO2007084314A2
(fr)
|
2006-01-12 |
2007-07-26 |
Incyte Corporation |
MODULATEURS de la 11-ß HYDROXYSTEROIDE DESHYDROGENASE DE TYPE 1, LEURS COMPOSITIONS PHARMACEUTIQUES ET LEURS PROCEDES D'UTILISATION
|
|
CN101374455B
(zh)
|
2006-02-27 |
2013-10-16 |
拜尔健康护理有限责任公司 |
用于生物传感器系统的温度调节的分析物测定
|
|
WO2007101270A1
(fr)
|
2006-03-02 |
2007-09-07 |
Incyte Corporation |
MODULATEURS DE LA 11β-HYDROXYSTEROIDE DESHYDROGENASE DE TYPE 1, COMPOSITIONS PHARMACEUTIQUES LES COMPRENANT ET PROCEDE D'UTILISATION DESDITS MODULATEURS
|
|
US20070208001A1
(en)
|
2006-03-03 |
2007-09-06 |
Jincong Zhuo |
Modulators of 11- beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
|
|
WO2007109456A2
(fr)
|
2006-03-16 |
2007-09-27 |
Pharmacopeia, Inc. |
Biphényle isoxazole sulfonamides substituées en tant que double antagonistes des récepteurs angiotensine et endothéline
|
|
JP2007254409A
(ja)
|
2006-03-24 |
2007-10-04 |
Taisho Pharmaceut Co Ltd |
イミダゾリジノン誘導体
|
|
US7435833B2
(en)
|
2006-04-07 |
2008-10-14 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
|
CN101426769A
(zh)
|
2006-04-20 |
2009-05-06 |
杜邦公司 |
五元杂环无脊椎害虫防治剂
|
|
US7981918B2
(en)
|
2006-04-21 |
2011-07-19 |
Eli Lilly And Company |
Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
|
AU2007240450B2
(en)
|
2006-04-21 |
2011-12-22 |
Eli Lilly And Company |
Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
|
JP5265521B2
(ja)
|
2006-04-21 |
2013-08-14 |
イーライ リリー アンド カンパニー |
１１−β−ヒドロキシステロイドデヒドロゲナーゼ１阻害剤としてのビフェニルアミドラクタム誘導体
|
|
ES2346925T3
(es)
|
2006-04-24 |
2010-10-21 |
ELI LILLY & COMPANY |
Pirrolidinonas sustituidas como inhibidores de la 11 beta-dihidroesteroide deshidrogenasa 1.
|
|
EA015499B1
(ru)
|
2006-04-25 |
2011-08-30 |
Эли Лилли Энд Компани |
Ингибиторы 11-бета-гидроксистероид дегидрогеназы типа 1
|
|
US8178005B2
(en)
|
2006-06-20 |
2012-05-15 |
Chemtura Corporation |
Liquid phosphite compositions having different alkyl groups
|
|
TW200811170A
(en)
|
2006-06-27 |
2008-03-01 |
Sanofi Aventis |
Urea derivatives of tropane, their preparation and their therapeutic application
|
|
WO2008012623A1
(fr)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Composés de benzimidazolyle constituant des potentialisateurs du sous-type de récepteur de glutamate mglur2
|
|
WO2008012622A2
(fr)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Composés d'azabenzimidazolyle
|
|
WO2008021338A2
(fr)
|
2006-08-15 |
2008-02-21 |
Wyeth |
Dérivés d'oxazolidone tricycliques utiles en tant que modulateurs du récepteur de la progestérone
|
|
US7649007B2
(en)
|
2006-08-15 |
2010-01-19 |
Wyeth Llc |
Oxazolidine derivatives as PR modulators
|
|
US7538107B2
(en)
|
2006-08-15 |
2009-05-26 |
Wyeth |
Oxazinan-2-one derivatives useful as PR modulators
|
|
US8927715B2
(en)
|
2006-08-25 |
2015-01-06 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11β-hydroxysteroid dehydrogenase type 1
|
|
WO2008031227A1
(fr)
|
2006-09-14 |
2008-03-20 |
Neuromed Pharmaceuticals Ltd. |
Composés de diaryle piperidine utilisés en tant que bloqueurs de canaux calciques
|
|
KR20090053923A
(ko)
|
2006-09-22 |
2009-05-28 |
노파르티스 아게 |
헤테로시클릭 유기 화합물
|
|
DE102007005799B4
(de)
|
2006-10-18 |
2018-01-25 |
Heinz-Jürgen Mühlen |
Verfahren zur Erzeugung eines wasserstoffreichen Produktgases
|
|
AU2007312391B2
(en)
|
2006-10-19 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Imidazolone and imidazolidinone derivatives as 11b-HSD1 inhibitors for diabetes
|
|
TW200829171A
(en)
|
2006-11-17 |
2008-07-16 |
Nihon Nohyaku Co Ltd |
Haloalkyl sulfonanilide derivatives or salts thereof, herbicide using it as effective constituent and use-method thereof
|
|
EP1935420A1
(fr)
|
2006-12-21 |
2008-06-25 |
Merck Sante |
Dérivés du 2-adamantyl-butyramide en tant qu'inhibiteurs selectifs de la 11beta-HSD1
|
|
JP5486928B2
(ja)
|
2007-02-26 |
2014-05-07 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１のサイクリックウレアおよびカルバメートインヒビター
|
|
US20100104534A1
(en)
|
2007-03-23 |
2010-04-29 |
Srikanth Venkatraman |
Hydrazido-peptides as inhibitors of hcv ns3-protease
|
|
CN101646679A
(zh)
|
2007-03-29 |
2010-02-10 |
弗·哈夫曼-拉罗切有限公司 |
杂环抗病毒化合物
|
|
ATE554078T1
(de)
|
2007-07-26 |
2012-05-15 |
Vitae Pharmaceuticals Inc |
Synthese von 11-beta-hydroxysteroid-dehydrogenase-1-hemmern
|
|
WO2009020140A1
(fr)
|
2007-08-06 |
2009-02-12 |
Dainippon Sumitomo Pharma Co., Ltd. |
Dérivé d'adamantylurée
|
|
JP2009110842A
(ja)
|
2007-10-31 |
2009-05-21 |
Sumitomo Chemical Co Ltd |
ボタンスイッチ被覆用積層樹脂体
|
|
AR069207A1
(es)
|
2007-11-07 |
2010-01-06 |
Vitae Pharmaceuticals Inc |
Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
|
|
TW200927115A
(en)
|
2007-11-16 |
2009-07-01 |
Boehringer Ingelheim Int |
Aryl-and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
|
|
WO2009075835A1
(fr)
|
2007-12-11 |
2009-06-18 |
Vitae Pharmaceutical, Inc |
Inhibiteurs cycliques d'urée de la 11-hydroxystéroïde déhydrogénase 1
|
|
KR101460359B1
(ko)
|
2007-12-13 |
2014-11-10 |
삼성전자주식회사 |
이동통신 시스템에서의 핸드오버 방법 및 장치
|
|
TW200934490A
(en)
|
2008-01-07 |
2009-08-16 |
Vitae Pharmaceuticals Inc |
Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
|
|
CA2712500A1
(fr)
|
2008-01-24 |
2009-07-30 |
Vitae Pharmaceuticals, Inc. |
Carbazate cyclique et inhibiteurs du type semi-carbazide de la 11beta-hydroxysteroide deshydrogenase 1
|
|
JP5734666B2
(ja)
|
2008-02-11 |
2015-06-17 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１の１，３−オキサアゼパン−２−オン及び１，３−ジアゼパン−２−オン阻害剤
|
|
WO2009100872A1
(fr)
|
2008-02-12 |
2009-08-20 |
Boehringer Ingelheim International Gmbh |
Dérivés d’urée de benzomorphanes et structures associées, médicaments contenant de tels composés et leur utilisation
|
|
US8598160B2
(en)
|
2008-02-15 |
2013-12-03 |
Vitae Pharmaceuticals, Inc. |
Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
|
JP5108557B2
(ja)
|
2008-02-27 |
2012-12-26 |
東京エレクトロン株式会社 |
ロードロック装置および基板冷却方法
|
|
EP2265588B1
(fr)
|
2008-02-27 |
2013-06-26 |
Vitae Pharmaceuticals, Inc. |
INHIBITEURS DE LA 11ß -HYDROXYSTÉROÏDE DÉSHYDROGÉNASE DE TYPE 1
|
|
CA2718264A1
(fr)
|
2008-03-18 |
2009-09-24 |
Vitae Pharmaceuticals, Inc. |
Inhibiteurs de la 11-beta-hydroxysteroide deshydrogenase de type 1
|
|
TW200944526A
(en)
|
2008-04-22 |
2009-11-01 |
Vitae Pharmaceuticals Inc |
Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
|
AR071236A1
(es)
|
2008-05-01 |
2010-06-02 |
Vitae Pharmaceuticals Inc |
Inhibidores ciclicos de la 11beta-hidroxiesteroide deshidrogenasa 1
|
|
US8242111B2
(en)
|
2008-05-01 |
2012-08-14 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
|
CA2723034A1
(fr)
|
2008-05-01 |
2009-11-05 |
Vitae Pharmaceuticals, Inc. |
Inhibiteurs cycliques de la 11-beta-hydroxysteroide dehydrogenase 1
|
|
CA2722427A1
(fr)
|
2008-05-01 |
2009-11-05 |
Vitae Pharmaceuticals, Inc. |
Inhibiteurs cycliques de la 11-beta-hydroxysteroide dehydrogenase 1
|
|
US8765780B2
(en)
|
2008-05-13 |
2014-07-01 |
Boehringer Ingelheim International Gmbh |
Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
|
|
US20110224242A1
(en)
|
2008-07-23 |
2011-09-15 |
Bioalliance Pharma |
Styrlyquinolines, their process of preparation and their therapeutic uses
|
|
WO2010010149A1
(fr)
|
2008-07-23 |
2010-01-28 |
Bioalliance Pharma |
Styrylquinolines, leur procédé de préparation et leurs utilisations thérapeutiques
|
|
CN102105454A
(zh)
|
2008-07-25 |
2011-06-22 |
贝林格尔.英格海姆国际有限公司 |
合成1型11β-羟基类固醇脱氢酶的抑制剂
|
|
PL2324018T3
(pl)
|
2008-07-25 |
2014-02-28 |
Boehringer Ingelheim Int |
Cykliczne inhibitory dehydrogenazy 11 beta-hydroksysteroidowej typu 1
|
|
CA2730208C
(fr)
|
2008-07-25 |
2016-10-25 |
Boehringer Ingelheim International Gmbh |
Acides 1,1'-diadamantyl carboxyliques, medicaments contenant de tels composes et application associee
|
|
CA2729998A1
(fr)
|
2008-07-25 |
2010-01-28 |
Boehringer Ingelheim International Gmbh |
Inhibiteurs de la 11 beta-hydroxysteroide deshydrogenase 1
|
|
JP5586605B2
(ja)
|
2008-08-25 |
2014-09-10 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
置換ノルトロパンのアリール及びヘテロアリールカルボニル誘導体、該化合物を含有する医薬及びその使用
|
|
JP5544366B2
(ja)
|
2008-10-23 |
2014-07-09 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
置換ノルトロパンの尿素誘導体、該化合物を含有する医薬及びその使用
|
|
CA2750517A1
(fr)
|
2009-02-04 |
2010-08-12 |
Vitae Pharmaceuticals, Inc. |
Inhibiteurs cycliques de 11 beta-hydroxysteroide deshydrogenase 1
|
|
EP2393807B1
(fr)
|
2009-02-04 |
2013-08-14 |
Boehringer Ingelheim International GmbH |
Inhibiteurs cycliques de la 11beta -hydroxystéroïde déshydrogénase 1
|
|
EP2405913A1
(fr)
|
2009-03-09 |
2012-01-18 |
Bristol-Myers Squibb Company |
Analogues de pyridone utiles comme antagonistes du récepteur 1 de l'hormone concentrant la mélanine
|
|
GEP20156309B
(en)
|
2009-04-30 |
2015-07-10 |
Vitae Pharmaceuticals Inc |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
JP5670440B2
(ja)
|
2009-06-02 |
2015-02-18 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状阻害剤
|
|
AR076936A1
(es)
|
2009-06-02 |
2011-07-20 |
Vitae Pharmaceuticals Inc |
Inhibidores de carbamato y urea de la 11 beta hidroxiesteroide deshidrogenasa 1
|
|
EP2440537A1
(fr)
|
2009-06-11 |
2012-04-18 |
Vitae Pharmaceuticals, Inc. |
Inhibiteurs cycliques de la 11-bêta-hydroxystéroïde déshydrogénase 1 basée sur la structure 1,3-oxazinan-2-one
|
|
JP5749263B2
(ja)
|
2009-07-01 |
2015-07-15 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター
|
|
US20110071115A1
(en)
|
2009-09-11 |
2011-03-24 |
Cylene Pharmaceuticals, Inc. |
Pharmaceutically useful heterocycle-substituted lactams
|
|
US8552212B2
(en)
|
2009-11-05 |
2013-10-08 |
Boehringer Ingelheim International Gmbh |
Chiral phosphorus ligands
|
|
UY33001A
(es)
|
2009-11-06 |
2011-05-31 |
Boehringer Ingelheim Int |
Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina
|
|
WO2011159760A1
(fr)
|
2010-06-16 |
2011-12-22 |
Vitae Pharmaceuticals, Inc. |
Hétérocycles à 5, 6 et 7 chaînons substitués, médicaments contenant ces composés et leur utilisation
|
|
WO2011161128A1
(fr)
|
2010-06-25 |
2011-12-29 |
Boehringer Ingelheim International Gmbh |
Azaspirohexanones comme inhibiteurs de 11-β-hsd1 pour le traitement de troubles métaboliques
|
|
CN103179960A
(zh)
|
2010-11-02 |
2013-06-26 |
贝林格尔.英格海姆国际有限公司 |
治疗代谢疾病的药物组合
|